Unravelling the cardiac conundrum of amyloidosis: an experience from a tertiary care centre

Sohini Parveen Sarwala; Subhrajyoti Karmakar; Keya Basu

doi:10.18203/2320-6012.ijrms20251660

Authors

Sohini Parveen Sarwala Department of Pathology, IPGMER-SSKMH, Kolkata, India https://orcid.org/0000-0002-0823-4413
Subhrajyoti Karmakar Department of Pathology, IPGMER-SSKMH, Kolkata, India https://orcid.org/0000-0002-9603-1877
Keya Basu Department of Pathology, IPGMER-SSKMH, Kolkata, India https://orcid.org/0000-0002-3960-2469

DOI:

https://doi.org/10.18203/2320-6012.ijrms20251660

Keywords:

Cardiac amyloidosis, Endomyocardial biopsy, Congo red, Lambda light chain restriction

Abstract

Amyloidosis encompasses a spectrum of diseases caused due to extracellular deposition of misfolded proteins in body. The most common subtypes that infiltrate cardiac tissue are AL, ATTRwt (wild type), ATTRv (mutated) and Isolated atrial amyloidosis. Here, we elaborate such an interesting case of cardiac AL amyloidosis. A 69-year-old male presented with shortness of breath and restrictive cardiomyopathy. Further endomyocardial biopsy showed acellular, light eosinophilic deposit. Direct immunofluorescence showed lambda light chain restriction, concordant with elevated serum free λ light chain level. Finally, positive Congo red stain with apple green birefringence under polarised light clinched the diagnosis of Cardiac AL Amyloidosis. Endomyocardial biopsy with congo red stain and immunofluorescence is indispensable for diagnosis and subtyping of AL amyloidosis. This sets apart other amyloid subtypes and cardiac light chain deposition disease. Early diagnosis of cardiac amyloidosis subtype is imperative to guide the therapy and evaluate the prognosis of the patient.

Metrics

Metrics Loading ...

References

Robbins S, Cotran R. Diseases of the immune system. Robbins and Cotran pathologic basis of disease. 9th ed. Philadelphia: Elsevier Saunders. 2013:791-809.

Leung N, Nasr SH. 2024 Update on Classification, Etiology, and Typing of Renal Amyloidosis: A Review. Am J Kidney Dis. 2024;84(3):361-73. DOI: https://doi.org/10.1053/j.ajkd.2024.01.530

Buxbaum, JN, Dispenzieri A, Eisenberg DS, Fändrich M, Merlini G, Saraiva MJM, et al. Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 2022;29(4):213–9. DOI: https://doi.org/10.1080/13506129.2022.2147636

Collins AB, Smith RN, Stone JR. Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence. Cardiovasc Pathol. 2009;18(4):205-16. DOI: https://doi.org/10.1016/j.carpath.2008.05.004

Edwards A, Paulsen M, Lasky B, Ramanathan V. Cardiac amyloidosis: a case review series. J Integr Cardiol. 2015;1(2):40-5. DOI: https://doi.org/10.15761/JIC.1000114

Taiwo AA, Alapati L, Movahed A. Cardiac amyloidosis: A case report and review of literature. World J Clin Cases. 2019;7(6):742-52. DOI: https://doi.org/10.12998/wjcc.v7.i6.742

Flodrova P, Flodr P, Pika T, Vymetal J, Holub D, Dzubak P, et al. Cardiac amyloidosis: from clinical suspicion to morphological diagnosis. Pathol. 2018;50(3):261-8. DOI: https://doi.org/10.1016/j.pathol.2017.10.012

Picken MM, Herrera GA. Amyloidosis. In: Jennette JC, D’Agati VD, Fogo AB, Nickeleit V, Stokes MB. Heptinstall’s Pathology of the Kidney.8th ed. Philadelphia: Wolters Kluwer. 2024: 391-423.

Osanami A, Yano T, Takemura G, Ikeda H, Inyaku M, Toda Y, et al. Cardiac Light Chain Deposition Disease Mimicking Immunoglobulin Light Chain Amyloidosis: Two Branches of the Same Tree. Circ Cardiovasc Imag. 2020;13(9):1-3. DOI: https://doi.org/10.1161/CIRCIMAGING.120.010478